CONCLUSION: Prenatal glucocorticoid use was associated with modestly increased risks of ASD and ADHD. However, residual confounding by maternal disease severity remained a major limitation and a specific medication-related effect could not be conclusively established. Glucocorticoid use should focus on the lowest dose and shortest duration, with clear counselling. Further research is required.
